Jessica Fye Analyst Performance

Managing Director, Equity Research Analyst - Biotechnology at JPMorgan Chase & Co.

Jessica Fye is a stock analyst at JPMorgan Chase & Co. focused in the medical sector, covering 32 publicly traded companies. Over the past year, Jessica Fye has issued 54 stock ratings, including buy, hold, and sell recommendations. While full access to Jessica Fye's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jessica Fye's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

88 Last 10 Years

Buy Recommendations

59.52% 50 Buy Ratings

Companies Covered

32 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	59.5%	50 ratings
Hold	38.1%	32 ratings
Sell	2.4%	2 ratings

Out of 84 total stock ratings issued by Jessica Fye at JPMorgan Chase & Co., the majority (59.5%) have been Buy recommendations, followed by 38.1% Hold and 2.4% Sell.

Best & Worst Calls

• Best Call

  0000.0%

  NKTR

  Mar 2017

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  ESPR

  Sep 2015

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	32 companies

Jessica Fye, an analyst at JPMorgan Chase & Co., currently covers 32 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 31 companies	96.9%
	Miscellaneous 1 company	3.1%

Jessica Fye of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector, with additional focus on companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 17 companies	53.1%
MED - DRUGS 7 companies	21.9%
PHARMACEUTICAL PREPARATIONS 6 companies	18.8%
Miscellaneous 1 company	3.1%
BIOTECHNOLOGY 1 company	3.1%

Jessica Fye's Ratings History at JPMorgan Chase & Co.

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
BMRN BioMarin Pharmaceutical	10/9/2025	Boost Price Target	$54.69	$119.00	Overweight	$0.00 00.00% ROI
ASND Ascendis Pharma A/S	10/9/2025	Boost Price Target	$210.13	$264.00	Overweight	$0.00 00.00% ROI
INCY Incyte	10/9/2025	Boost Price Target	$85.38	$89.00	Neutral	$0.00 00.00% ROI
LEGN Legend Biotech	10/9/2025	Lower Price Target	$31.56	$76.00	Overweight	$0.00 00.00% ROI
IONS Ionis Pharmaceuticals	10/8/2025	Upgrade	$68.94	$80.00	Overweight	$0.00 00.00% ROI
ONC BeOne Medicines	10/8/2025	Boost Price Target	$352.25	$385.00	Overweight	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	10/8/2025	Boost Price Target	$419.51	$530.00	Overweight	$0.00 00.00% ROI
CRNX Crinetics Pharmaceuticals	9/24/2025	Lower Price Target	$35.86	$52.00	Overweight	$0.00 00.00% ROI
BNTX BioNTech	9/22/2025	Boost Price Target	$96.22	$121.00	Neutral	$0.00 00.00% ROI
MIRM Mirum Pharmaceuticals	9/12/2025	Boost Price Target	$75.99	$77.00	Overweight	$0.00 00.00% ROI
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ALKS Alkermes	9/9/2025	Boost Price Target	$27.87	$35.00	Neutral	$0.00 00.00% ROI
LEGN Legend Biotech	8/25/2025	Boost Price Target	$35.31	$78.00	Overweight	$0.00 00.00% ROI
IONS Ionis Pharmaceuticals	8/25/2025	Boost Price Target	$42.56	$49.00	Neutral	$0.00 00.00% ROI
INCY Incyte	8/22/2025	Boost Price Target	$85.99	$73.00	Neutral	$0.00 00.00% ROI
INSM Insmed	8/20/2025	Boost Price Target	$128.94	$135.00	Overweight	$0.00 00.00% ROI
ASND Ascendis Pharma A/S	8/19/2025	Boost Price Target	$194.89	$260.00	Overweight	$0.00 00.00% ROI
HALO Halozyme Therapeutics	8/7/2025	Boost Price Target	$61.52	$63.00	Neutral	$0.00 00.00% ROI
ALNY Alnylam Pharmaceuticals	8/6/2025	Boost Price Target	$428.14	$475.00	Overweight	$0.00 00.00% ROI
MRNA Moderna	8/1/2025	Set Price Target	$29.56	$26.00		$0.00 00.00% ROI
ASND Ascendis Pharma A/S	7/29/2025	Boost Price Target	$162.53	$254.00	Overweight	$0.00 00.00% ROI
ONC BeOne Medicines	7/17/2025	Boost Price Target	$288.92	$345.00	Overweight	$0.00 00.00% ROI
ALNY Alnylam Pharmaceuticals	7/16/2025	Boost Price Target	$311.12	$348.00	Overweight	$0.00 00.00% ROI
HALO Halozyme Therapeutics	7/16/2025	Boost Price Target	$57.91	$60.00	Neutral	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	7/14/2025	Boost Price Target	$472.44	$517.00	Overweight	$0.00 00.00% ROI
INCY Incyte	7/14/2025	Lower Price Target	$69.09	$67.00	Neutral	$0.00 00.00% ROI
BMRN BioMarin Pharmaceutical	7/14/2025	Boost Price Target	$58.75	$113.00	Overweight	$0.00 00.00% ROI
INSM Insmed	7/8/2025	Boost Price Target	$96.75	$111.00	Overweight	$0.00 00.00% ROI
UTHR United Therapeutics	7/8/2025	Lower Price Target	$297.61	$330.00	Overweight	$0.00 00.00% ROI
ONC BeOne Medicines	6/27/2025	Boost Price Target	$254.49	$321.00	Overweight	$0.00 00.00% ROI
IONS Ionis Pharmaceuticals	6/12/2025	Boost Price Target	$35.79	$48.00	Neutral	$0.00 00.00% ROI
ALNY Alnylam Pharmaceuticals	6/12/2025	Boost Price Target	$297.32	$338.00	Overweight	$0.00 00.00% ROI
MRNA Moderna	5/22/2025	Lower Price Target	$25.76	$26.00	Underweight	$0.00 00.00% ROI
BNTX BioNTech	5/22/2025	Lower Price Target	$98.95	$116.00	Neutral	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	5/6/2025	Boost Price Target	$443.41	$515.00	Overweight	$0.00 00.00% ROI
BCRX BioCryst Pharmaceuticals	5/6/2025	Boost Price Target	$10.59	$13.00	Overweight	$0.00 00.00% ROI
ASND Ascendis Pharma A/S	5/2/2025	Boost Price Target	$169.83	$245.00	Overweight	$0.00 00.00% ROI
UTHR United Therapeutics	5/1/2025	Lower Price Target	$296.52	$350.00	Overweight	$0.00 00.00% ROI
ONC BeOne Medicines	4/21/2025	Boost Price Target	$230.64	$317.00	Overweight	$0.00 00.00% ROI
INCY Incyte	4/21/2025	Lower Price Target	$56.60	$68.00	Neutral	$0.00 00.00% ROI
HALO Halozyme Therapeutics	4/21/2025	Boost Price Target	$57.24	$58.00	Neutral	$0.00 00.00% ROI
UTHR United Therapeutics	4/21/2025	Lower Price Target	$283.69	$355.00	Overweight	$0.00 00.00% ROI
IMCR Immunocore	4/14/2025	Lower Price Target	$26.59	$50.00	Overweight	$0.00 00.00% ROI
NVCR NovoCure	4/10/2025	Lower Price Target	$16.14	$28.00	Neutral	$0.00 00.00% ROI
ALNY Alnylam Pharmaceuticals	3/24/2025	Upgrade	$283.34	$328.00	Overweight	$0.00 00.00% ROI
IONS Ionis Pharmaceuticals	3/24/2025	Lower Price Target	$32.91	$45.00	Neutral	$0.00 00.00% ROI
MRNA Moderna	3/21/2025	Lower Price Target	$32.29	$33.00	Underweight	$0.00 00.00% ROI
ASND Ascendis Pharma A/S	3/18/2025	Boost Price Target	$168.84	$200.00	Overweight	$0.00 00.00% ROI
ALNY Alnylam Pharmaceuticals	3/11/2025	Boost Price Target	$236.20	$280.00	Neutral	$0.00 00.00% ROI
IONS Ionis Pharmaceuticals	3/11/2025	Lower Price Target	$31.94	$47.00	Neutral	$0.00 00.00% ROI
JAZZ Jazz Pharmaceuticals	2/26/2025	Boost Price Target	$145.09	$209.00	Overweight	$0.00 00.00% ROI
MRNA Moderna	2/14/2025	Set Price Target	$35.53	$45.00		$0.00 00.00% ROI
ASND Ascendis Pharma A/S	2/13/2025	Boost Price Target	$145.21	$168.00	Overweight	$0.00 00.00% ROI
INSM Insmed	2/7/2025	Boost Price Target	$79.95	$92.00	Overweight	$0.00 00.00% ROI
ASND Ascendis Pharma A/S	1/29/2025	Boost Price Target	$129.37	$167.00	Overweight	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.